Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus.
BACKGROUND
Alpha-1-antitrpsin (AAT) is the main antiprotease of plasma. Concentration of serum alpha-1-antitrypsin (AAT) may not be delegate of the functional capacity of this antiprotease. To our knowledge there is not any report regarding the functional level of AAT in gestational diabetes mellitus (GDM). The aim of the present study was to determine serum trypsin inhibitory capacity (sTIC) in gestational diabetes mellitus.


METHODS
This case-control study was performed in 41 GDM and 40 healthy pregnant women. sTIC was measured by enzymatic assay.


RESULTS
The serum trypsin inhibitory capacity was significantly lower (p<0.001) in GDM (5.84+/-2.27 micromol/min/ml) than healthy pregnant women (7.24+/-1.91 micromol/min/ml).


CONCLUSIONS
In gestational diabetes mellitus reduction of serum trypsin inhibitory capacity may be due to non-enzymatic glycosylation of alpha-1-antitrypsin or oxidation of methionin in the active site of alpha-1-antitrypsin which remains to be cleared.
Yaghmaei
Minoo
M
Department of Obstetrics and Gynecology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Hashemi
Mohammad
M
Shikhzadeh
Abdolsamad
A
Mokhtari
Mojgan
M
Niazi
Abbasali
A
Ghavami
Saeid
S
D016022:Case-Control Studies; D016640:Diabetes, Gestational / Q000097:blood*; D005260:Female; D006801:Humans; D011247:Pregnancy / Q000097:blood*; D012016:Reference Values; D014361:Trypsin Inhibitors / Q000097:blood*; D000515:alpha 1-Antitrypsin / Q000097:blood*
D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin